Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-14-000047
Filing Date
2014-11-10
Accepted
2014-11-10 15:23:11
Documents
13
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 1008111
2 exhibt10.htm EX-10 45160
3 exhibit12.htm EX-12 57777
4 exhibit31_1.htm EX-31.1 13882
5 exhibit31_2.htm EX-31.2 13864
6 exhibit32_1.htm EX-32.1 3421
7 exhibit32_2.htm EX-32.2 3379
  Complete submission text file 0001367644-14-000047.txt   6628957

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ebs-20140930.xml EX-101.INS 951821
9 XBRL TAXONOMY EXTENSION SCHEMA ebs-20140930.xsd EX-101.SCH 38952
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20140930_cal.xml EX-101.CAL 73226
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20140930_def.xml EX-101.DEF 174717
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20140930_lab.xml EX-101.LAB 587212
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20140930_pre.xml EX-101.PRE 324060
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 141208343
SIC: 2834 Pharmaceutical Preparations